Improving the treatment of Epstein-Barr virus infectious mononucleosis in children

Journal Title: Актуальна інфектологія - Year 2018, Vol 6, Issue 2

Abstract

Background. In Ukraine, as in the whole world, there is a tendency to increase in the number of diffuse liver diseases. Increased percentage of patients with liver disease among adults is mostly determined by the damages to hepatobiliary system in childhood. The purpose of the study was to evaluate the effectiveness of ursodeoxycholic acid (UDCA) in the therapy of liver damages due to Epstein-Barr virus (EBV). Materials and methods. Research design: prospective, open-label, controlled. Sixty children with EBV infectious mononucleosis (IM) aged 1 to 18 years old were screened. All patients were observed, examined during the acute period of the disease, and divided into 2 groups. The children of the main group (n = 35) received standard therapy for EBV IM in combination with UDCA, patients of the control group (n = 25) received standard treatment alone. Results. Received data showed that therapy improved by means of UDCA in EBV IM and liver damage promotes a faster regression of the main symptoms of infection, such as fever, appetite loss and jaundice, already on day 7 from the beginning of treatment and a more rapid norma­lization of indicators of the functional state of the liver (alanine aminotransferase, bilirubin, alkaline phosphatase, gamma glutamyltransferase, lactate dehydrogenase). The drug was well tolerated, no adverse reactions were observed. Conclusions. The inclusion of UDCA in the treatment scheme can improve the effectiveness of advanced therapy compared with standard one, promotes a more rapid regression of infection symptoms and a more rapid norma­lization of indicators of the functional state of the liver.

Authors and Affiliations

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya

Keywords

Related Articles

Phyto-inhalation for treatment of complications of acute respiratory viral diseases

Inhalations (inhalation of medicinal substances) are one of the effective ways to treat upper respiratory tract diseases and colds. Inhalation therapy is used to treat rhinitis, sinusitis, tonsillitis, pharyngitis, laryn...

Diagnostic and Therapeutic Difficulties in Children with Viral Exanthema in the Practice of General Practitioners

The article presents data on viral exanthema caused by Coxsackie enterovirus (Coxsackie A16) in children. The features of the course and the difficulty in the diagnosis and treatment of this disease in the arid region ar...

State of Antiendotoxic Immunity Antiendotoxin and Metabolic Intoxication in Acute Intestinal Infections

The paper presents the comparative analysis of antiendotoxic immunity parameters and free-radical oxidation in the blood of 34 patients with acute intestinal infections of rotavirus and rotavirus-bacterial etiology depen...

Latent tuberculosis infection: the possibility of quantiferon test

The review deals with the problem of diagnosis of latent tuberculosis infection (LTI). The article presents information about LTI screening tests: their sensitivity, specificity, advantages and disadvantages. The possibi...

Download PDF file
  • EP ID EP289583
  • DOI 10.22141/2312-413x.6.2.2018.131095
  • Views 76
  • Downloads 0

How To Cite

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya (2018). Improving the treatment of Epstein-Barr virus infectious mononucleosis in children. Актуальна інфектологія, 6(2), 87-92. https://europub.co.uk/articles/-A-289583